OEM Stratasys launches 3D printer specifically for medical applications

OEM Stratasys, a leading 3D printer, has launched a medically upgraded variant of its award-winning J750 system. The J750 Digital Anatomy 3D printer has been designed explicitly for healthcare professionals. Models made from these materials, either for pre-surgical planning or for training, simulate live-tissue, provide surgeons with a more realistic environment, and a no-risk setting to perform complex operations. The printer is compatible with a new range of materials from Stratasys that have been specifically designed for making anatomical models. The J750’s medical use has been validated for Materialise’s FDA-approved Mimics inPrint software, a move that might encourage more practitioners to opt for Stratasys 3D printers.

After receiving Materialise’s approval, the Hospital Center University De Bordeaux (CHU de Bordeaux) situated in France became one of the first few hospitals across the globe to house a J750 on-site. In September, personalized medical device maker Bone 3D followed suit and bought its own J750 for the production of surgical guides and simulators. The J750 Digital Anatomy 3D printer retains the features of its predecessor’s, although, with one key difference i.e., the new printer can function with three specialist materials. The company has also launched three new materials along with the new Digital Anatomy system viz., TissueMatrix, BoneMatrix, and GelMatrix. TissueMatrix is a soft, translucent, and flexible material designed especially for the replication of heart tissue. BoneMatrix is a sturdy yet flexible material used to represent bones in an anatomical model. GelMatrix is a support material that can be used inside small cavities of anatomical models and is formulated for use in vessels with an inner diameter and wall thickness as low as 1.0 mm.

Apart from TissueMatrix, BoneMatrix, and GelMatrix resins, the new J750 Digital Anatomy 3D printer is compatible with the Vero family of resins as well as Agilus30 flexible materials. Stratasys is also planning to launch a Blood Vessel Cleaning Station to support the removal of the material.

Purushottam Gaurav

About the author